Interscalene Versus Combined Infraclavicular-suprascapular Nerve Blocks

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

August 31, 2020

Study Completion Date

September 30, 2020

Conditions
Postoperative Pain
Interventions
PROCEDURE

ICSSB group

At supine position with abducted limb, the probe of ultrasound will be translocated in costoclavicular space; the subclavian artery will be identified. The three cords of the brachial plexus will be visualized lateral to the artery. By using an in-plane technique and a cephalad-to-caudate direction, the block needle will be advanced until its tip will be in the middle of three cords and 10 mL of 0.25 % bupivacaine Hydrochloride will be injected. Then at lateral decubitus position, by using in-plane technique the probe will be translocated in suprascapular fossa, lateral-to-medial direction, the block needle will be advanced until its tip in the floor of the suprascapular fossa ventral to the fascia of the supraspinatus muscle and 10 mL of 0.25 % bupivacaine Hydrochloride will be injected .

PROCEDURE

ISB group

The probe of ultrasound will be applied in lateral side of the neck at the level of the cricoid cartilage to obtain a view of the three hypoechoic structures which represent the roots of the brachial plexus. Using an in-plane technique and a lateral to-medial direction, the block needle will be advanced until its tip will be positioned under the prevertebral fascia between the two most superficial hypoechoic structures and 10 mL of 0.25 % bupivacaine Hydrochloride will be injected at level of C5-6 and another 10 ml of 0.25 % bupivacaine Hydrochloride will be injected at level of C7-8.

Trial Locations (1)

63514

Fayoum University hospital, El Fayoum Qesm

All Listed Sponsors
lead

Fayoum University Hospital

OTHER

NCT03628950 - Interscalene Versus Combined Infraclavicular-suprascapular Nerve Blocks | Biotech Hunter | Biotech Hunter